Bioimplant formulation comprising lecithin and stearin

Details Bioimplant formulation comprising lecithin and stearin Bioimplant formulation comprising lecithin and stearin

2007-03-27

2011-11-08

Azpuru, Carlos (Department: 1617)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Reexamination Certificate

active

08052982

ABSTRACT:
Pharmaceutical and/or veterinary formulation containing about 2-30% (w/w) (on an active basis) of at least one active agent, about 0.5-20.0% (w/w) of a pore-forming agent comprising lecithin and an organic salt, and the balance stearin.

REFERENCES:
patent: 4578391 (1986-03-01), Kawata et al.
patent: 4981681 (1991-01-01), Tosti
patent: 6337318 (2002-01-01), Trigg et al.
patent: 6913761 (2005-07-01), Trigg et al.
patent: 0 353 045 (1990-01-01), None
patent: 0 523 330 (1992-04-01), None
patent: 0 523 330 (1993-01-01), None
patent: 2 167 662 (1986-06-01), None
patent: 9-104626 (1997-04-01), None
patent: WO 91/05548 (1991-05-01), None
patent: WO 91/07171 (1991-05-01), None
patent: WO 94/08623 (1994-04-01), None
patent: WO 96/40049 (1996-12-01), None
patent: WO 97/00693 (1997-01-01), None
patent: WO 97/03634 (1997-02-01), None
patent: WO 97/15285 (1997-05-01), None
patent: WO 98/02146 (1998-01-01), None
patent: WO 98/08533 (1998-03-01), None
patent: WO 99/48500 (1999-09-01), None

Affiliated with

Also associated with

Rating

Bioimplant formulation comprising lecithin and stearin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bioimplant formulation comprising lecithin and stearin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bioimplant formulation comprising lecithin and stearin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4266125